[Intravitreal triamcinolone injection in the treatment of idiopathic juxtafoveal telangiectasis].
Case report of one idiopathic juxtafoveal telangiectasis (IJT) 1A patient whose right eye was treated with a 4 mg intravitreal triamcinolone acetonide injection. The outcome was evaluated by visual acuity and optic coherence tomography. The visual acuity and the caliper retinal thickness before triamcinolone injection were respectively 20/100 and 569 microm, and 20/60 and 371 microm after three weeks and 20/100 and 614 microm after six week of follow-up. The stabilization of the vascular wall due to the intravitreal triamcinolone injection leads to a transitory improvement in vision and reduction in macular edema in the TJI 1A eyes. No permanent help by the photocoagulation could be shown.
Maia
Otacílio Oliveira
OO
Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil. omaiausp@uol.com.br
Takahashi
Walter Yukihiko
WY
Bonanomi
Maria Teresa Brizzi C
MT
Nascimento
Vinícius Paganini
VP
Melo
Carlos Sérgio Nascimento de
CS
D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007267:Injections; D008269:Macular Edema / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012164:Retinal Diseases / Q000188:drug therapy*; D012171:Retinal Vessels / Q000187:drug effects* / Q000473:pathology; D013684:Telangiectasis / Q000628:therapy*; D013997:Time Factors; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D014792:Visual Acuity; D014822:Vitreous Body / Q000187:drug effects
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide